Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants

Purpose An evaluation was made of the effectiveness in changing prescribing behavior of ‘Dear Health Professional (DHP)’ letters mailed by the manufacturer to physicians and other health professionals advising them of safety information on co‐prescribing of tramadol and antidepressants. Methods A re...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2005-03, Vol.14 (3), p.149-154
Hauptverfasser:	Shatin, Deborah, Gardner, Jacqueline S., Stergachis, Andy, Blough, David, Graham, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Analgesics, Opioid - adverse effects Analgesics, Opioid - therapeutic use antidepressants Antidepressive Agents - adverse effects Antidepressive Agents - therapeutic use codispensing Cohort Studies contraindicated Dear Doctor Drug Industry - methods Drug Industry - statistics & numerical data Drug Prescriptions - statistics & numerical data Drug Therapy, Combination Drug Utilization Review - methods Drug Utilization Review - statistics & numerical data drugs/adverse effects Humans Information Dissemination - methods Insurance, Pharmaceutical Services - statistics & numerical data postmarketing Practice Patterns, Physicians product surveillance Retrospective Studies risk communication Time Factors tramadol Tramadol - adverse effects Tramadol - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!